Synthesis modules / TRACERlab FX2 C
TRACERlab FX2 C
- Manufacturer
- GE HealthCare
- Cassette-based
- No
- Syntheses indexed
- 7
From the manufacturer
No manufacturer-submitted profile yet. Everything above comes from published papers, not from TRACERlab FX2 C itself.
Yields from different papers are not directly comparable: starting activity, decay correction and scale differ between groups. Read the count of independent reports rather than the highest number. Why
From the literature
What has been made on it
| Agent | Cassette | Purification | Yield % | Min | Regulatory | Source |
|---|---|---|---|---|---|---|
| [11C]acetate | custom manifold | SPE | 35.8 ± 9.9% | 10 | — | 41452397 2025 |
| [11C]acetoacetate | custom manifold | HPLC | 4.67 ± 1.36% | 15 | — | 41452397 2025 |
| [11C]AMT | — | — | 13 ± 7.5 % | — | — | 40306184 2025 |
| [11C]AMT | — | — | 10.4 ± 4.1 % | — | — | 40306184 2025 |
| [11C]6-bromopurine | fixed tubing | HPLC+SPE | 20.5 ± 5.2% | 43 min | CTA | 38683266 2024 |
| [11C]methionine | — | SPE | 20 ± 5% | — | — | 33153893 2021 |
| [18F]fluoroethylcholine | — | SPE | 8 ± 3% | — | — | 33153893 2021 |
Choosing a synthesis module?Tell us what you plan to produce and we will help you compare TRACERlab FX2 C against the alternatives.
Get in touch